These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 29465067)
1. Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-β)/Smad4 Signalling Pathway. Yuan X; Zhang Z; Jiang K; Wang X; Li Y Med Sci Monit; 2018 Feb; 24():1080-1088. PubMed ID: 29465067 [TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. Chou JL; Su HY; Chen LY; Liao YP; Hartman-Frey C; Lai YH; Yang HW; Deatherage DE; Kuo CT; Huang YW; Yan PS; Hsiao SH; Tai CK; Lin HJ; Davuluri RV; Chao TK; Nephew KP; Huang TH; Lai HC; Chan MW Lab Invest; 2010 Mar; 90(3):414-25. PubMed ID: 20065949 [TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma. Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237 [TBL] [Abstract][Full Text] [Related]
5. SMAD4/DPC4 expression and prognosis in human colorectal cancer. Isaksson-Mettävainio M; Palmqvist R; Forssell J; Stenling R; Oberg A Anticancer Res; 2006; 26(1B):507-10. PubMed ID: 16739311 [TBL] [Abstract][Full Text] [Related]
6. Significance of positive and inhibitory regulators in the TGF-β signaling pathway in colorectal cancers. Coates RF; Gardner JA; Gao Y; Cortright VM; Mitchell JM; Ashikaga T; Skelly J; Yang MX Hum Pathol; 2017 Aug; 66():34-39. PubMed ID: 28601657 [TBL] [Abstract][Full Text] [Related]
7. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487 [TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328 [No Abstract] [Full Text] [Related]
9. Investigating the impact of SMAD2 and SMAD4 downregulation in colorectal cancer and their correlation with immune markers, prognosis, and drug resistance and sensitivity. Amani MS; Peymani M Mol Biol Rep; 2024 Jul; 51(1):831. PubMed ID: 39037563 [TBL] [Abstract][Full Text] [Related]
10. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis. Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973 [TBL] [Abstract][Full Text] [Related]
11. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation. Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319 [TBL] [Abstract][Full Text] [Related]
12. Pregnancy-specific glycoprotein 9 (PSG9), a driver for colorectal cancer, enhances angiogenesis via activation of SMAD4. Yang L; Hu S; Tan J; Zhang X; Yuan W; Wang Q; Xu L; Liu J; Liu Z; Jia Y; Huang X Oncotarget; 2016 Sep; 7(38):61562-61574. PubMed ID: 27528036 [TBL] [Abstract][Full Text] [Related]
13. Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer. Gulubova M; Manolova I; Ananiev J; Julianov A; Yovchev Y; Peeva K Int J Colorectal Dis; 2010 May; 25(5):591-9. PubMed ID: 20165854 [TBL] [Abstract][Full Text] [Related]
14. Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma. Fan J; Yang MX; Ouyang Q; Fu D; Xu Z; Liu X; Mino-Kenudson M; Geng J; Tang F Hum Pathol; 2016 Sep; 55():151-8. PubMed ID: 27195906 [TBL] [Abstract][Full Text] [Related]
15. Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer. Ai X; Wu Y; Zhang W; Zhang Z; Jin G; Zhao J; Yu J; Lin Y; Zhang W; Liang H; Datta PK; Zhang M; Zhang B; Chen X Cancer Biol Ther; 2013 Nov; 14(11):1059-67. PubMed ID: 24025354 [TBL] [Abstract][Full Text] [Related]
16. TGF-β promotes colorectal cancer cell growth in vitro and in vivo. Sun G; Cao D; Sun Z; Zhou K; Wang Y; Liu H Hepatogastroenterology; 2013 Jun; 60(124):715-9. PubMed ID: 23178467 [TBL] [Abstract][Full Text] [Related]
17. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer. Yi W; Xiao E; Ding R; Luo P; Yang Y Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871 [TBL] [Abstract][Full Text] [Related]
18. Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation. Yang L; Wang N; Tang Y; Cao X; Wan M Hum Mutat; 2006 Sep; 27(9):897-905. PubMed ID: 16865698 [TBL] [Abstract][Full Text] [Related]
19. SCF(beta-TrCP1) controls Smad4 protein stability in pancreatic cancer cells. Wan M; Huang J; Jhala NC; Tytler EM; Yang L; Vickers SM; Tang Y; Lu C; Wang N; Cao X Am J Pathol; 2005 May; 166(5):1379-92. PubMed ID: 15855639 [TBL] [Abstract][Full Text] [Related]
20. Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers. Chun HK; Jung KU; Choi YL; Hong HK; Kim SH; Yun SH; Kim HC; Lee WY; Cho YB Oncology; 2014; 86(3):159-69. PubMed ID: 24643220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]